Bay Street News, 2020

SEATTLE, April 27, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and […]

MONTREAL, April 27, 2020 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (Nasdaq:DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North […]

WESTLAKE, Texas, April 27, 2020 (GLOBE NEWSWIRE) — Core-Mark Holding Company, Inc. (NASDAQ: CORE), announced today that it will release […]

SOUTH SAN FRANCISCO, Calif., April 27, 2020 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company […]

Randomized controlled investigator-initiated trial (IIT) of non-invasive vagus nerve stimulation (nVNS) therapy currently enrolling COVID-19 patients in SpainPeer-reviewed paper, “Use […]

NEWTOWN, Pa., April 27, 2020 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused […]

NEW YORK, April 27, 2020 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and […]

DELRAY BEACH, Fla., April 27, 2020 (GLOBE NEWSWIRE) — PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for […]

EL SEGUNDO, Calif., April 27, 2020 (GLOBE NEWSWIRE) — Landmark Infrastructure Partners LP (the “Partnership”) (NASDAQ: LMRK) announced today that […]

•  Program to focus on enhanced blood oxygenation and reduction in patient progression to Intensive Care Units•  Patient enrollment planned for both the […]